Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial

Overview of attention for article published in European Journal of Cancer (1965), March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 13 news outlets
blogs: 2 blogs
policy: 1 policy source
twitter: 32 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user
reddit: 2 Redditors
guideline: 1 clinical guideline source

Readers on

mendeley: 116 Mendeley

So far, Altmetric has seen 1 Guideline that references this research output.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Clinical guideline published by American Society for Radiation Oncology (ASTRO) on 11 Oct 2018

The American Society for Radiation Oncology (ASTRO) is a leading organization dedicated to advancing the practice of radiation oncology. It focuses on improving patient care through education, research, and the development of clinical guidelines for radiation therapy.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.